NCT00862082 2013-08-23
Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Proacta, Incorporated
Phase 1/2 Terminated
Clinical Trials
5 trialsNCT00544674 2012-12-10
PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
Proacta, Incorporated
Phase 2 Terminated
NCT00349167 2012-11-30
PR-104 in Treating Patients With Advanced Solid Tumors
Proacta, Incorporated
Phase 1 Completed
NCT00616213 2011-06-01
PR104 and G-CSF in Treating Patients With Solid Tumors
Proacta, Incorporated
Phase 1 Completed
NCT00459836 2011-03-02
PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
Proacta, Incorporated
Phase 1 Completed